Moderator: Sarah Dineen-Griffin, Lecturer in health services management and leadership, Charles Sturt University, Australia Panellist: Hadi Dassouki, Community Pharmacist, Lebanon Jack Collins, Postdoctoral Research Associate, The University of Sydney School of Pharmacy, Australia Joanne Crook, Consultant Pharmacist Paediatrics, Kings College Hospital, UK Watch video Digital event video 15 December 2021, 13:00 - 14:30 CET FIP Setting goals for the decade ahead | Episode 21 - FINALE | FIP DG 11: Impact & outcomes More The FIP Development Goals Digital Programme Setting goals for the decade ahead is a comprehensive online event series providing coverage of the 21 goals over 21 events in 2021
Many companies aside from Lilly and Novo Nordisk are also jumping on the train, testing their own GLP-1s in clinical trials, which could help with shortages in the future
These products may aggravate nausea, increase heart rate, and worsen dizzinessparticularly in individuals whose appetite and caloric intake are already significantly reduced by GLP-1 medications
Glutathione affects melanin production through multiple mechanisms
A letter of medical necessity does not override the prior authorization criteria